Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.

A number of potential neuroleptic drugs of the substituted benzamide type have been compared with some reference neuroleptic drugs regarding their affinities for rat brain receptors using in vitro receptor binding techniques. The effects on dopamine-stimulated adenylate cyclase were also investigated. All 6-methoxysalicylamides were very potent inhibitors of the dopamine-D2 receptor and possessed much less affinity for other receptors as well as for the dopamine-stimulated adenylate cyclase. In contrast, the classical neuroleptic drugs were not selective dopamine-D2 receptor blockers. Several of these neuroleptics were thus potent inhibitors of alpha 1-receptors, 5-HT2 receptors, muscarinic receptors and histamine-H1 receptors. Sulpiride was the most selective dopamine-D2 receptor blocker of the reference compounds with a selectivity ratio of 65. The 6-methoxysalicylamides had selectivity ratios ranging from 18 to 167.

[1]  H. Hall,et al.  Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro. , 2009, Acta pharmacologica et toxicologica.

[2]  C. Köhler,et al.  Dopamine D2 receptors and dopamine metabolism Relationship between biochemical and behavioural effects of substituted benzamide drugs , 1986, Neuropharmacology.

[3]  H. Hall,et al.  Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors. , 1986, European journal of pharmacology.

[4]  Y. Kumar,et al.  POTENTIAL NEUROLEPTIC AGENTS. 3. CHEMISTRY AND ANTIDOPAMINERGIC PROPERTIES OF F SUBSTITUTED 6-METHOXYSALICYLAMIDES , 1985 .

[5]  S. Ögren,et al.  SYNTHESIS, CRYSTAL STRUCTURE AND ANTIDOPAMINERGIC PROPERTIES OF ETICLOPRIDE (FLB 131) , 1985 .

[6]  Y. Kumar,et al.  Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides. , 1985, Journal of medicinal chemistry.

[7]  S O Ogren,et al.  Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.

[8]  H. Hall,et al.  Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain. , 1985, European journal of pharmacology.

[9]  E. Richelson,et al.  Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. , 1984, European journal of pharmacology.

[10]  H. Hall,et al.  Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. , 1984, European journal of pharmacology.

[11]  J. Gerlach,et al.  NEW DRUGS AND PERSPECTIVES IN ANTIPSYCHOTIC TREATMENT , 1984 .

[12]  K. Fuxe,et al.  Studies on the Mechanism of Action of Substituted Benzamide Drugs , 1984, Acta psychiatrica Scandinavica. Supplementum.

[13]  P. Jenner,et al.  Multiple Dopamine Receptors in Brain and the Pharmacological Action of Substituted Benzamide Drugs , 1984, Acta psychiatrica Scandinavica. Supplementum.

[14]  S. Ogren,et al.  Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities. , 1982, Journal of medicinal chemistry.

[15]  C. Marsden,et al.  Substituted benzamide drugs as selective neuroleptic agents. , 1981, Neuropharmacology.

[16]  S. Snyder,et al.  Two distinct central serotonin receptors with different physiological functions. , 1981, Science.

[17]  H. Hall,et al.  Effects of antidepressant drugs on different receptors in the brain. , 1981, European journal of pharmacology.

[18]  P. Seeman Brain dopamine receptors. , 1980, Pharmacological reviews.

[19]  C. Marsden,et al.  The substituted benzamides--a novel class of dopamine antagonists. , 1979, Life sciences.

[20]  H. Hall,et al.  Evaluation of a semiautomatic filtration technique for receptor binding studies. , 1979, Life sciences.

[21]  P. Seeman,et al.  Anti-schizophrenic drugs--membrane receptor sites of action. , 1977, Biochemical pharmacology.

[22]  D. Roberts,et al.  Synthesis and pharmacological properties of a series of antidopaminergic piperidyl benzamides * , 1977, The Journal of pharmacy and pharmacology.

[23]  S. Snyder,et al.  Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. , 1976, Molecular pharmacology.

[24]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[25]  P. Seeman,et al.  Conversion of dopamine D1 receptors from high to low affinity for dopamine. , 1985, Biochemical pharmacology.

[26]  D. Sibley,et al.  The classification of dopamine receptors: relationship to radioligand binding. , 1983, Annual review of neuroscience.